MDMA continues to be the leading voice in Congress driving
the efforts to repeal the medical device tax.
The grassroots efforts of MDMA members have been
instrumental in garnering a 79-20 vote in the Senate to include device tax repeal
as a priority, and over 260 bipartisan cosponsors on repeal legislation in the
House of Representatives.
CLICK HERE TO VIEW MILESTONES OF THE
EFFORTS TO REPEAL THE MEDICAL DEVICE TAX
Engagement by MDMA members and industry has resulted in
hearings in both the House and Senate with witnesses testifying to the
devastating impact of the tax, and over 1000 stakeholders signing a letter sent
to Senate and House leadership calling for repeal.
MDMA Medical Device Tax Working Group meets on an "as needed" basis via teleconference. Email notification will be sent to all working group participants when a call has been scheduled. If you would
like to join this working group, click here.
Med Tech Coalition Applauds Historic House Vote
MDMA, AdvaMed, MITA commended the House of Representatives for passing...
MDMA Statement on House Ways & Means Committee Markup of Legislation to Repeal the Medical Device Tax
MDMA issued the following statement today in response to the House W & M Committee Markup of Legislation to Repeal the Medical Device Tax...
House Freshman Members of Congress Send Letter Urging a Vote on Device Tax Repeal
Led by Congresswoman Elise Stefanik (NY), freshman representative to the House Policy Committee, a bipartisan group of Members of the House...
MDMA Survey Shows Repealing the Medical Device Tax Would Create Jobs, Increase R&D
A new survey conducted by the Medical Device Manufactures Association (MDMA) shows that if the medical device tax was repealed, the overwhelming majority...
MDMA, AdvaMed & MITA Applaud Bipartisan Senate Effort to Repeal the Device Tax
MDMA, AdvaMed & MITA today applauded the Senate re-introduction of bipartisan legislation to repeal the increasingly damaging medical device...
MDMA, AdvaMed & MITA Support Bipartisan Efforts to Repeal the Device Tax
MDMA, AdvaMed & MITA today applauded the introduction of bipartisan legislation to repeal the 2.3 percent medical device excise...
MDMA Statement on House Jobs Package
"MDMA thanks the House of Representatives for working to strengthen medical technology innovation by removing a major roadblock..."
Treasury Inspector General Issues Report Calling IRS Collection of Medical Device Tax Problematic
A report released by the Treasury Inspector General for Tax Administration (TIGTA) showed that collecting and estimating payments from device companies for the medical device excise tax is becoming increasingly problematic….
MDMA Statement on Medical Device Tax Repeal Efforts in Senate Finance Committee
"While we are disappointed the medical device tax was not addressed as a part of the tax extenders legislation, we remain enthusiastic about the growing bipartisan agreement that Congress..."
MDMA Statement on Device Tax Repeal Inclusion in Tax Reform Plan
Mark Leahey, President & CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement regarding inclusion of medical device tax repeal in House Ways and Means Chairman Dave Camp's Tax reform plan…